The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy

HPB

Volumn 15, Issue 6, 2013, Pages 463-472

  Parkin, Ed ^a,b   O'Reilly, Derek A ^a,b   Adam, Rene ^c   Kaiser, Gernot M ^f   Laurent, Christophe ^e   Elias, Dominique ^d   Capussotti, Lorenzo ^g   Renehan, Andrew G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COLON RESECTION; COLORECTAL LIVER METASTASIS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPLICATION; EUROPE; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; ODDS RATIO; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SECONDARY; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; EUROPE; FATTY LIVER; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877704585     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12007     Document Type: Article

References (33)

1. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. (2000) Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 132: 112-117. (Pubitemid 30044177)
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395. (Pubitemid 39657013)
3. Angulo P,. (2002) Non-alcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
4. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. (2005) Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 41: 1313-1321. (Pubitemid 40770284)
5. Fabbrini E, Sullivan S, Klein S,. (2010) Obesity and non-alcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
6. Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M,. (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578. (Pubitemid 351232031)
7. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. (2009) Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11: 547-563.
8. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM,. (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200: 845-853. (Pubitemid 40744790)
9. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072. (Pubitemid 46622116)
10. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236: 397-406; discussion 406-407.
11. Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, et al. (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94: 1395-1402. (Pubitemid 350144389)
12. Pathak S, Tang JM, Terlizzo M, Poston GJ, Malik HZ,. (2010) Hepatic steatosis, body mass index and longterm outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol 36: 52-57.
13. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM,. (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2: 292-298. (Pubitemid 128409616)
14. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, et al. (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7: 1034-1044. (Pubitemid 37524071)
15. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA,. (2007) Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 245: 923-930. (Pubitemid 46809294)
16. Terminology Committee of the International Hepato-Pancreato-Biliary Association. (2000) Brisbane 2000 terminology of liver anatomy and resections. HPB 2: 333-339.
17. de Meijer VE, Kalish BT, Puder M, Ijzermans JN,. (2000) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97: 1331-1339.
18. Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, et al. (2011) Sinusoidal obstruction syndrome impairs longterm outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 18: 421-430.
19. Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, et al. (2010) Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 252: 774-787.
20. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, et al. (2010) Liver resection of colorectal metastases in elderly patients. Br J Surg 97: 366-376.
21. Vigano L, Capussotti L, Barroso E, Nuzzo G, Laurent C, Ijzermans JN, et al. (2012) Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 19: 2786-2796.
22. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213. (Pubitemid 38963009)
23. Punt CJ, Buyse M, Kohne CH, Hohenberger P, Labianca R, Schmoll HJ, et al. (2007) Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 99: 998-1003. (Pubitemid 47232601)
24. Hosmer DW, Lemeshow S, May S,. (2008) Applied Survival Analysis: Regression Modeling of Time to Event Data. New York: Wiley.
25. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135.
26. Kantartzis K, Machann J, Schick F, Fritsche A, Haring HU, Stefan N,. (2010) The impact of liver fat vs. visceral fat in determining categories of prediabetes. Diabetologia 53: 882-889.
27. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, et al. (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299: 506-515.
28. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. (2009) Body mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
29. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN,. (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99: 550-557.
30. Simkens LH, Koopman M, Mol L, Veldhuis GJ, Ten Bokkel Huinink D, Muller EW, et al. (2011) Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur J Cancer 47: 2560-2567.
31. Rawlins SR, El-Zammar O, Zinkievich JM, Newman N, Levine RA,. (2010) Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C. Dig Dis Sci 55: 2049-2057.
32. Li M, Song J, Mirkov S, Xiao SY, Hart J, Liu W,. (2011) Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. Hum Pathol 42: 356-360.
33. Jones RP, Vauthey JN, Adam R, Rees M, Berry D, Jackson R, et al. (2012) Effect of specialist decision making on treatment strategies for colorectal liver metastases. Br J Surg 99: 1263-1269.